Like many on Wall Street, Treasury Secretary Scott Bessent used a limited partnership to avoid Medicare taxes. Unlike the others, he’s now overseeing the I.R.S.

President Trump announced a deal with Eli Lilly and Novo Nordisk to lower prices on hugely popular weight-loss drugs for Medicare, Medicaid and American patients who pay with their own money.

The president’s agreement with drug companies involves a range of prices, depending on dose, product and how you’re paying.

Fall enrollment is on. Some plans are raising premiums for Part D, which covers prescriptions, by $50 or more per month, while others are lowering them.

An estimated 3,000 employees seem to be affected. The federal agency said the return to work would occur Monday, with the costs paid by user fees collected from researchers.

The main difference is that most Americans don’t confront the full cost of their coverage.

More older adults have turned to cochlear implants after Medicare expanded eligibility for the devices.

The budget bill signed by President Trump suspended an effort to enroll more low-income older Americans in programs that assist them with rising health care costs.

The F.D.A. approved Merck’s injected version of its blockbuster infusion Keytruda. The company says it will be quicker and easier, but it stands to slow the adoption of cheaper competitors and increase costs by billions of dollars.

A pilot program in six states will use a tactic employed by private insurers that has been heavily criticized for delaying and denying medical care.